Basel Medical GroupBMGL

13F holders, Q4 2025 (December 31)
10holders
6new positions
6sold out
2famous investors
$0.49avg. 13F price*

At the end of Q4 2025, 10 institutions reported holding Basel Medical Group Ltd. (BMGL) in their 13F filings, unchanged from Q3 2025. 6 opened new positions and 6 sold out. The largest holders were Ground Swell Capital, LLC ($17K), XTX Topco Ltd ($15K) and Citadel Advisors ($12K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Basel Medical Group Ltd.
CUSIP
G0864B103
Latest filing quarter
Q1 2026

History

Number of 13F holders

0246810 Q2 2025: 6Q2 2025Q3 2025: 10Q3 2025Q4 2025: 10Q4 2025Q1 2026: 4Q1 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions6$54K
Exits6$344K

All 13F filers, Q3 2025 → Q4 2025: 112,402 shares bought and 258,653 shares sold, net −146,251 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Ground Swell Capital, LLC 0.03% New 33,705 $17K
XTX Topco Ltd 0.00% New 30,430 $15K
Citadel Advisors 0.00% Reduce -73.5% 24,672 $12K
Jane Street Group, LLC 0.00% New 16,288 $8K
Susquehanna International Group, LLP 0.00% New 15,290 $7K
Renaissance Technologies 0.00% New 14,498 $7K
UBS Group AG 0.00% Add +37.1% 8,089 $4K
Bell Investment Advisors, Inc 0.00% No change 248 $122
Citigroup Inc. 0.00% New 1 $0
Coston, McIsaac & Partners 0.00% No change 50 $0

"% of holder's portfolio" is BMGL's weight in each manager's 13F, not the share of Basel Medical Group Ltd. the manager owns.